Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusion imaging

International Journal of Cardiology

Volumn 117, Issue 2, 2007, Pages 157-164

  Zaid, Gh ^a   Tanchilevitch, A ^a   Rivlin, E ^a   Gropper, R ^a   Rosenschein, U ^a,b   Lanir, A ^a   Goldhammer, E ^a,b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

B type natriuretic peptide; Ischemia; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; ISRAEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE STRESS; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCINTILLATION CAMERA; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL MODEL; THORAX PAIN; TREADMILL EXERCISE;

AGED; BIOLOGICAL MARKERS; EXERCISE TEST; EXERTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; REST; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33947415302     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.013     Document Type: Article

References (26)

1. Erpiner E.A., Ritchards A.M., and Yandle T.G. Natriuretic hormones. Endocrinol Metab Clin North Am 24 3 (1995) 481-509
2. Mair J., Hammerer-Lercher A., and Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 39 7 (2001) 571-588
3. Protter A.A., Wallace A.M., and Ferraris V.A. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 9 5 (1996) 432-436
4. Colucci W.S., Elkayam U., and Horton D.P. Intravenous nesiritide, a natriuretic peptide in the treatment of decompensated heart failure. N Engl J Med 343 4 (2000) 246-253
5. Jensen K.T., Carstens L., and Pedersen E.B. Effect of BNP on renal hemodynanics, tubular function and vasoactive hormones in humans. Am J Physiol 274 (1998) f63-f72 [supp]
6. Puplication Committee for the VMAC Investigators (vasodilation in the management of acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 12 (2002) 1531-1540
7. Okumura K., Yasue H., and Fuji H. Effect of brain natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in human: comparison with effect on systemic hemodynamic variables. J Am Coll Cardiol 25 2 (1995) 342-348
8. Abasi Z., Karram T., and Ellaham S. Implication of natriuretic peptide system in the pathogenesis of heart failure. Pharmacol Ther 102 3 (2004) 223-241
9. Hokamaki J., Kawano Ah., and Yoshimura M. Urinary biopyrins levels are elevated in relation to severity of heart failure. J Am Coll Cardiol 43 10 (2004) 1880-1885
10. Martinez-Selles M. B-type natriuretic peptide in the elevation of acute dyspnea. N Engl J Med 350 23 (2004) 2416-2417
11. Dao Q., Krishnaswamy P., Kasanegra R., et al. Utility of B-type natriuretic peptide in diagnosis of congestive heart failure in an urgent setting. J Am Coll Cardiol 37 2 (2001) 440-444
12. Habbs R.E., Mills R.M., and Young G.B. An update on nesiritide for treatment of decompensated heart failure. Expert Opin Investig Drugs 10 5 (2001) 935-942
13. Kellete J. Prediction of in hospital mortality by brain natriuretic peptide level and other independent variables in acutely ill patients with suspected heart disease. Can J Cardiol 209 7 (2004) 686-690
14. Galvani M., Ottani F., and Oltrona I. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndrome. Circulation 110 2 (2004) 128-134
15. Weber M., Dill Th., Arnold R., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 4 (2004) 612-620
16. Maisel A.S., Krishnaswamy P., and Nowak R.M. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
17. Bibbins-Domingo K., Ansari M., and Shiller N.B. B-type natriuretic peptide and ischemia in patients with stable coronary disease. Circulation 108 24 (2003) 2987-2992
18. Galvani M., Ferrini D., and Ottani F. Natriueritic peptide for risk stratification of patients with acute coronary syndrome. Eur J Heart Fail 6 3 (2004) 327-333
19. de-Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndrome. N Engl J Med 345 14 (2001) 1014-1021
20. Morrow D.A., de Lemos J.A., and Sabatine M.S. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-segment elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI-18. J Am Coll Cardiol 41 8 (2003) 1264-1272
21. Choi E.Y., Kwon H.M., and Yoon Y.W. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level. Yonsei Med J Korea 45 2 (2004) 255-262
22. Asada J., Tsuji H., Iwasaka T., et al. Usefulness of plasma brain natriuretic peptide level in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 93 6 (2004) 702-704
23. Foote R.S., Pearlman J.D., Siegel A.H., et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 10 (2004) 1980-1987
24. Sabatine M.S., Marrow D.A., de Lemos J.A., et al. Acute changes in circulating natriuretic peptide level in relation to myocardial ischemia. J Am Coll Cardiol 10 (2004) 1988-1995
25. Cerqueira M.D., and Lawrence A. Nuclear cardiology update. Radiol Clin North Am 39 50 (2001) 931-946
26. Norton-Wenzel C.S. NCCLS guidelines. Clin Chem 51 (2005) 1085-1086